Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors
Status:
Recruiting
Trial end date:
2024-08-21
Target enrollment:
Participant gender:
Summary
An open-label, multicenter, phase Ia/Ib study to evaluate the safety, tolerance and
preliminary efficacy of IBI319 in patients with advanced malignant tumors